Cytek
IPOFull Spectrum Flow Cytometry Systems | Discover the Advantages
Fremont, United States · $132.0M raised
- Headquarters
- Fremont, California
- Employees
- 201–500
- Business Model
- B2B
- Website
- cytekbio.com
- Total Funding
- $132.0M
- Last Round
- $120.0M Series DNov 2020
- Rounds
- 4
About
Leading manufacturer of full spectrum flow cytometry systems and cell analysis solutions for cancer and cell biology research.
Summary
Cytek is a Biotech company based in Fremont, United States. It has raised $132.0M in total across 4 rounds, most recently a $120.0M Series D round in Nov 2020. Investors include Northern Light Ventures.
Tech & App Stack
10 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jul 2021
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company